Scientific Presentations

Press releases
Corporate presentation
Scientific Presentations
Scientific Publications
Events and webcasts
Stock information
SEC filings
Financial Statements
Regulated information
Voting Rights & Share Capital
ATM Program
General meetings
Governance
The board and committee members
Corporate governance documents
FAQ
IR Inquiry
All 2024 2023 2022 2021
11 Oct 2022
16:26 E.S.T.

TALEN®-mediated engineering of HSPC enables systemic delivery of IDUA - ESGCT 2022- Abstract

Download the PDF file
11 Oct 2022
14:33 E.S.T.

TALEN®-mediated engineering of HSPC enables systemic delivery of IDUA- ESGCT 2022- Poster Presentation

Download the PDF file
13 Jul 2022
09:57 E.S.T.

COMY Presentation - The 8th world Congress on Controversies in Multiple Myeloma

Watch the video
10 Jun 2022
13:39 E.S.T.

Pre-Clinical Proof Of Concept Demonstrates Robust Activity Of UCART20x22 Dual CAR T-Cells For The Treatment Of B-Cell Malignancies - EHA 2022- Poster Presentation

Download the PDF file
10 Jun 2022
13:35 E.S.T.

Preliminary Results from the Flu/Cy/Alemtuzumab arm of the Phase I BALLI-01 Trial of UCART22- EHA 2022- Poster Presentation

Download the PDF file
16 May 2022
14:22 E.S.T.

Endowing Universal CAR T-cell with Immune-Evasive Properties Using TALEN® -Gene Editing- ASGCT 2022- Oral Presentation

Download the PDF file
11 Apr 2022
11:16 E.S.T.

UCART20x22: First allogeneic dual CAR T-cell therapy for the treatment of B-cell malignancies - AACR 2022 - Abstract

Download the PDF file
10 Apr 2022
16:41 E.S.T.

UCART20x22: First allogeneic dual CAR T-cell therapy for the treatment of B-cell malignancies - AACR 2022 - Poster Presentation

Download the PDF file
11 Dec 2021
10:57 E.S.T.

Pre-clinical Development of a Highly Efficient TALEN®- ASH 2021- Poster Presentation

Download the PDF file
11 Dec 2021
10:55 E.S.T.

Preliminary Results from the Flu/Cy/Alemtuzumab arm of the Phase I BALLI-01 Trial of UCART22- ASH 2021- Poster Presentation

Download the PDF file